Announcement
16 Mar 2021
On 16 March 2021, KABS Laboratories announced securing CAD 54.2 million funding from the government for the establishment of a new facility in Val-des-Sources and expansion of its Saint-Hubert facility.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
16 Mar 2021
Revocation date:
No revocation date
Updated: 16 Mar 2021
Financial grant
In force
On 16 March 2021, KABS Laboratories announced receiving CAD 54.2 million (USD 43.5 million) funding from the Strategic Innovation Fund for the establishment of a new facility in Val-des-Sources and...
Sign in to see more
Related State Acts
18 May 2021
Canada: Government announces funding for a Canadian biomanufacturing company
16 Mar 2021
Canada: Government provides funding to a Canadian biotechnology company through Phase II clinical trials of a therapeutic candidate against COVID-19
16 Mar 2021
Canada: Novocol Pharma secures funding from the Canadian government
23 Mar 2020
Canada: Government allocates CAD 792 million for the development and production of medical countermeasures to COVID-19
Threads
See all
This state act is not part of any Thread yet.